SEARCH

SEARCH BY CITATION

References

  • Ancolio K., Alves da Costa C., Ueda K., Checler F. (2000) Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells. Neurosci. Lett. 285, 7982.
  • Bennett M., Bishop J., Leng Y., Chock P., Chase T., Mouradian M. (1999) Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274, 3385533858.
  • Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci 3, 13011306.
  • Canu N., Barbato C., Ciotti M. T., Serafino A., Dus L., Calissano P. (2000) Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20, 589599.
  • Ciechanover A. (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17, 71517160.
  • Cummings C. J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H. T., Beaudet A. L., Zoghbi H. Y. (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879892.
  • Drexler H. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94, 855860.
  • Feany M. B. & Bender W. W. (2000) A drosophila model of Parkinson's disease. Nature 404, 394398.
  • Figueiredo-Pereira M., Berg K., Wilk S. (1994) A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S Proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J. Neurochem. 63, 15781581.
  • Ghee M., Fournier A., Mallet J. (2000) Rat alpha-synuclein interacts with tat binding protein 1, a component of the 26S proteasomal complex. J. Neurochem. 75, 22212224.
  • Gibb W. & Lees A. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51, 745752.
  • Greene L. A. & Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 24242428.
  • Ii K., Ito H., Tanaka K., Hirano A. (1997) Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56, 125131.
  • Imai Y., Soda M., Takahashi R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 276, 3566135664.
  • Iwatsubo T., Yamaguchi H., Fujimuro M., Yokosawa H., Ihara Y., Trojanowski J. Q., Lee V. M. (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148, 15171529.
  • Johnston J. A., Ward C. L., Kopito R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 18831898.
  • Kim M., Lee H. S., LaForet G., McIntyre C., Martin E. J., Chang P., Kim T. W., Williams M., Reddy P. H., Tagle D., Boyce F. M., Won L., Heller A., Aronin N., DiFiglia M. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964973.
  • Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605608.
  • Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L., Riess O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106108.
  • Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P., Wilkinson K., Polymeropoulos M. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451452.
  • Lopes U., Ernhardt P., Yao R., Cooper G. (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272, 1289312896.
  • Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. (2000) Dopaminergic loss and inclusions body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 12651269.
  • McNaught K. S. & Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191194.
  • Ohtani-Kaneko R., Takada K., Iigo M., Hara M., Yokosawa H., Kawashima S., Hirata K. (1998) Proteasome inhibitors which induce neurite outgrowth from PC12h cellscause different subcellular accumulations of multi-ubiquitin chains. Neurochem. Res. 23, 14351443.
  • Pagano M., Tam S. W., Theodoras A. M., Beer-Romero P., Del Sal G., Chau V., Yew P. R., Draetta G. F., Rolfe M. (1995) Role of the ubiquitin-proteasome pathway in regulating the abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 631632.
  • Pasquini L. A., Besio Moreno M., Adamo A. M., Paquini J. M., Soto E. F. (2000) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59, 601611.
  • Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., Nussbaum R. L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 276, 20452047.
  • Qiu J. H., Asai A., Chi S., Saito N., Hamada H., Kirino T. (2000Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259265.
  • Rukenstein A., Rydel R. E., Green L. A. (1991) Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci. 11, 25522563.
  • Saudou F., Finbeiner S., Devys D., Greenberg M. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 5566.
  • Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302305.
  • Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839840.
  • Stefanis L., Park D. S., Yan C. Y., Farinelli S. E., Troy C. M., Shelanski M. L., G Reene L. A. (1996) Induction of CPP. 32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis. J. Biol. Chem. 271, 3066330671.
  • Stefanis L., Kholodilov N., Rideout H. J., Burke R. E., Greene L. A. (2001) Synuclein-1 is selectively upregulated in response to N. G. F. and treatment in PC12 cells. J. Neurochem. 761, 11651176.
  • Sulzer D. & Zecca L. (2000) Intraneuronal dopamine-quinone synthesis: a review. Neurotoxicity Res. 1, 181195.
  • Wojcik C., Schroeter D., Wilk S., Lamprecht J., Paweletz N. (1996) Ubiquitin-mediated proteolysis centers in HeLa cells: Indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur. J. Cell Biol. 71, 311318.